GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » Gross-Profit-to-Asset %

Etropal AD (XBUL:ETR) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Etropal AD Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Etropal AD's annualized Gross Profit for the quarter that ended in Dec. 2023 was лв0.00 Mil. Etropal AD's average Total Assets over the quarter that ended in Dec. 2023 was лв18.26 Mil. Therefore, Etropal AD's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.00%.


Etropal AD Gross-Profit-to-Asset % Historical Data

The historical data trend for Etropal AD's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD Gross-Profit-to-Asset % Chart

Etropal AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.02 31.97 18.88 18.67 22.31

Etropal AD Quarterly Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.12 18.80 18.30 23.95 -

Competitive Comparison of Etropal AD's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Etropal AD's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Etropal AD's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Etropal AD's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Etropal AD's Gross-Profit-to-Asset % falls into.


;
;

Etropal AD Gross-Profit-to-Asset % Calculation

Etropal AD's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=4.073/( (17.95+18.562)/ 2 )
=4.073/18.256
=22.31 %

Etropal AD's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (17.95+18.562)/ 2 )
=0/18.256
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Etropal AD Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Etropal AD's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Etropal AD Business Description

Traded in Other Exchanges
N/A
Address
191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.